IMRA: IMARA Inc. - Summary | Jitta

IMARA Inc.

NASDAQ:IMRA

Notice
Stock data is unavailable or the company’s delisted.
Price
$25.28
Loss Chance
58.0%
1.10JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (9)
Recent Business Performance (33)
Financial Strength (37)
Return to Shareholders (0)
Competitive Advantage (7)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
New Share IssuedMore than 50% in 5 years
CapExVery High
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
1.10
100.00%
2.48
473.03%
2.48
473.03%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
As of February 23, 2023, IMARA Inc. was acquired by Enliven Therapeutics, Inc., in a reverse merger transaction. IMARA Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts.